Pe'er Dar
<p>Dr Dar is the director of the division of fetal medicine at Montefiore Medical Center. He was trained in obstetrics and gynecology and high risk pregnancy in Israel and completed further training in obstetrics and gynecology and clinical genetics in the USA. In addition, Dr Dar completed training in fetal surgery in Europe.</p>
<p>Dr Dar is specialized in:</p>
<p>1. Prenatal diagnosis: Prenetal screening including First trimester screening for Down syndrome; Detailed fetal anatomy scans in early and late second trimester (including early transvaginal scans); Fetal echocardiography; Neurosonography; CVS; amniocentesis; cordocentesis and placental biopsies.</p>
<p>2. In Utero procedures and surgery: Fetoscopic laser ablation for twin to twin transfusion syndrome (TTTS), RFA for TRAP syndrome, EXIT procedures, Selective fetal reductions, fetal blood transfusions, in-utero placement of vesico-amniotic shunts and thoracoamniotic shunts; </p>
<p>Dr. Dar was trained in obstetrics and gynecology and high risk pregnancy in Israel and completed further training in obstetrics and gynecology and clinical genetics in the U.S. In addition, Dr. Dar completed training in fetal surgery in Europe. Dr. Dar specializes in prenatal screening, including first trimester screening for Down syndrome; Detailed fetal anatomy scans in early and late second trimester (including early transvaginal scans); Fetal echocardiography; Neurosonography; CVS; amniocentesis; cordocentesis and placental biopsies. He also performs in utero procedures and surgery, which includes Fetoscopic laser ablation for twin to twin transfusion syndrome (TTTS), RFA for TRAP syndrome, EXIT procedures, Selective fetal reductions, fetal blood transfusions, in-utero placement of vesico-amniotic shunts and thoracoamniotic shunts.</p>
<table><tbody><tr><td><span style="font-family:'Arial',sans-serif;color:#373A3C;">Prenatal diagnosis by ultrasound of placental and fetal abnormalities</span><br /><span style="font-family:'Arial',sans-serif;color:#373A3C;">Prenatal genetic diagnosis of fetal disorders</span><br /><span style="font-family:'Arial',sans-serif;color:#373A3C;">Management of pregnancies complicated by all fetal abnormalities</span><br /><span style="font-family:'Arial',sans-serif;color:#373A3C;">Management of complicated twin and other multiple pregnancies </span><br /><span style="font-family:'Arial',sans-serif;color:#373A3C;">Fetal therapy</span><br /><span style="font-family:'Arial',sans-serif;color:#373A3C;">Fetal surgery including fetsocopic surgery for TTTS </span> </td></tr></tbody></table>
<p style="line-height:150%;">Fetal medicine and surgery</p><p style="line-height:150%;">Non-invasive prenatal screening (cell free DNA)</p><p style="line-height:150%;">Scar pregnancies and placenta accreta spectrum (PAS)</p><p style="line-height:150%;">Ultrasound in obstetrics and gynecology</p>
<p style="text-align: left; padding-left: 30px;">1. Mazor M, <strong>Zitzer P</strong>, Chaim W, Maymon E, Kuperman O<em>. C-reactive protein as a marker of infection in women with preterm delivery.</em> Harefuah.[Hebrew] 1993:1;124(3); 132-137.</p>
<p style="text-align: left; padding-left: 30px;">2. Maymon R, <strong>Zitzer P</strong>, Manor Y, Bukovsky I, Moroz C<em>. Placental isoferitin patterns during normal first trimester and tubal gestations</em>. Hum Reprod. 1995:10(9); 2445-2447.</p>
<p style="text-align: left; padding-left: 30px;">3. Langer R, Pansky M,<strong> Zitzer P</strong>, Bukovsky I, Golan A<em>. National Urogynecologic Survey</em>. Isr J Obstet Gynecol. 1996 :7;145-149.</p>
<p style="text-align: left; padding-left: 30px;">4. <strong>Zitzer P</strong>, Panski M, Maymon R, Langer R, Bukovski I, Golan A. <em>Pelvic splenosis as a cause of low abdominal pain- Laparoscopic management</em>. Human Reprod. 1998 :13(6);101-103.</p>
<p style="text-align: left; padding-left: 30px;">5. Arieli S, <strong>Zitzer P</strong>, Bukovsky I, Maymon R<em>. Metabolic alkalosis at term pregnancy causing fetal deterioration and distress. </em>Isr J Obstet Gynecol 1999: 10; 61-63</p>
<p style="text-align: left; padding-left: 30px;">6. <strong>Dar P</strong>, Weiner I, Sofrin O, Sachs GS, Bukovsky I, Arieli S. <em>Clinical and sonographic fetal weight estimations in active labor with ruptured membranes</em>. J Reprod Med. 2000:45(5); 390-394.</p>
<p style="text-align: left; padding-left: 30px;">7. <strong>Dar P,</strong> Gross SJ. <em>Craniofacial and neck anomalies</em>. Clin Perinatol 2000;27(4);813-837</p>
<p style="text-align: left; padding-left: 30px;">8. <strong>Dar P</strong>, Gross SJ. <em>Macrosomia-a genetic perspective</em>. Clin Obstet Gynecol. 2000:43(2); 298-308.</p>
<p style="text-align: left; padding-left: 30px;">9. <strong>Dar P</strong>, Sachs GS, Strassburger D, Bukovsky I, Arieli S. <em>Ovarian function before and after salpingectomy in artificial reproductive technology patients</em>. Hum Reprod. 2000:15(1);142-144</p>
<p style="text-align: left; padding-left: 30px;">10. <strong>Dar P,</strong> Sachs SG, Carter SM, Ferreira JC, Nitowsky HM, Gross SJ. <em>Prenatal diagnosis of Bardet-Biedl syndrome by targeted second trimester sonography. </em>Ultrasound Obstet Gynecol 2001 Apr;17(4):354-6</p>
<p style="text-align: left; padding-left: 30px;">11. Sherer DM, <strong>Dar P</strong>. <em>Prenatal ultrasonographic diagnosis of congenital umbilical hernia and associated patent omphalomesenteric duct</em>. Gynecol Obstet Invest. 2001:51(1); 66-68</p>
<p style="text-align: left; padding-left: 30px;">12<em>.</em><strong> Dar P</strong>, Strassburger D, Shaish A, Levkovitz H, Halperin R, Harats R<em>.</em><em> Reduced reproduction with increased abortion rate in transgenic mice that overexpress 15-Lipoxygenase.</em>Gynecol Obstet Invest. 2001;52(1):18-21.</p>
<p style="text-align: left; padding-left: 30px;">13. <strong>Dar P</strong>, Javed AA, Ben-Yishay M, Ferreira JC, Paterson AD, Gross SJ, Chitayat D, Morrow BE, Nitowsky HM. <em>Potential Mapping of Corneal Dermoids to Xq24-qter</em>. J Med Genetics. 2001;38(10):719-23</p>
<p style="text-align: left; padding-left: 30px;">14. Halperin R, Zehavi S, <strong>Dar P</strong>, Habler L, Hadas E, Bukovsky I, Schneider D<em>. Clinical and molecular comparison between borderline serous ovarian tumors and advanced serous papillary ovarian carcinomas</em>. Eur J Gynaecol Oncol. 2001;22(4):292-6.</p>
<p style="text-align: left; padding-left: 30px;">15. Gross SJ, Ferreira JC, Morrow BE, <strong>Dar P,</strong> Funke B, Khabele D, Merkatz I. Gene expression profile of trisomy-21 placentas – a potential approach for designing non-invasive techniques of prenatal diagnosis. Am J Obstet Gynecol. 2002. 187(2):457-62</p>
<p style="text-align: left; padding-left: 30px;">16. Vaknin Z, Halperin R, Schneider D, Teitler J, <strong>Dar P</strong>, Herman A, Herman A, Berkovitch M. <em>Hyperemesis gravidarum and nonspecific abnormal EEG findings: a preliminary </em>report. J Reprod Med. 2006 ;51(8):623-7.</p>
<p style="text-align: left; padding-left: 30px;">17. Canick JA, Lambert-Messerlian GM, Palomaki GE, Neveux LM, Malone FD, Ball RH, Nyberg DA, Comstock CH, Bukowski R, Saade GR, Berkowitz RL, <strong>Dar P</strong>, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, D'Alton ME. First and Second Trimester Evaluation of Risk (FASTER) Trial Research Consortium. <em>Comparison of Serum Markers in First-Trimester Down Syndrome Screening.</em> Obstet Gynecol. 2006 ;108(5):1192-1199.</p>
<p style="text-align: left; padding-left: 30px;">18. Dugoff L, Cuckle HS, Hobbins JC, Malone FD, Belfort MA, Nyberg DA, Comstock CH, Saade GR, Eddelman KA, <strong>Dar P,</strong> Craigo AD, Timor Tritsch IE, Carr SR, Wolfe HM, D’alton ME <sup> </sup>for the FASTER Trial Research Consortium. <em>Prediction of patient-specific risk for fetal loss using maternal characteristics and first and second trimester maternal serum Down syndrome markers.</em> Am J Obstet Gynecol. 2008 Sep;199(3):290.e1-6.</p>
<p style="text-align: left; padding-left: 30px;">19. <strong>Dar P,</strong> Karmin I, Einstein MH. <em>Arteriovenous Malformations of the Uterus: Long-Term Follow-Up.</em> Gynecol Obstet Invest. 2008 11;66(3):157-161</p>
<p style="text-align: left; padding-left: 30px;">20. Rotenberg, O., Shahabi, S., Dar, P. <em>Testosterone secreting mature ovarian teratoma causing virilization in an adolescent - Sonographic and color Doppler characteristics.</em> J Ultrasound Med. 2009 ;28(1):85-8</p>
<p style="text-align: left; padding-left: 30px;">21. D’Alton ME, Cleary-Goldman J, Lambert-Messerlian G, Ball RH, Nyberg DA, Comstock CH, Bukowski R, Berkowitz RL, <strong>Dar P</strong>, Dugoff L, Craigo SD, Timor IE, Carr SR, Wolfe HM, Dukes K, Canick JA, Malone FD. <em>Maintaining quality assurance for nuchal translucency sonography: Lessons from the FASTER trial</em>. Ultrasound Obstet Gynecol. 2009 27;33(2):142-146</p>
<p style="text-align: left; padding-left: 30px;">22. Gebb J, <strong>Dar P</strong>. <em>Should the First Trimester Aneuploidy Screen be Maternal Age Adjusted? Screening by Absolute Risk vs. Risk Adjusted to Maternal Age.</em> Prenatal Diagnosis. 2009; 29 (3) 245-247</p>
<p style="text-align: left; padding-left: 30px;">23. Terry S., Banks E., Harris K., Duvivier R., <strong>Dar P</strong>. <em>Comparison of 3-dimensional to 2-dimensional Saline Infusion Sonohysterograms for the Evaluation of Intrauterine Abnormalities.</em> J Clinic Ultrasound. 2009 ;37(5):258-62.</p>
<p style="text-align: left; padding-left: 30px;">24. <strong>Dar P</strong>, Rosenthal J,Factor S, DubiossoR, Murthy AS <em>First trimester diagnosis of fetal epignathus with two and three-dimensional ultrasonography</em><strong>. </strong>J Ultrasound Med. 2009 Dec;28(12):1743-6</p>
<p style="text-align: left; padding-left: 30px;">25. Ram K, Goffman D, Ilagan J, <strong>Dar P</strong>. <em>First trimester diagnosis of familial split-hand split-foot malformation (SHFM)</em>. J Ultrasound Med. 2009 ;28(10):1397-400.</p>
<p style="text-align: left; padding-left: 30px;">26. <strong>Dar P</strong>, Gebb J, Reimers L, Bernstein PB, Chazotte C, Merkatz IR. <em>First trimester 3-dimensional power Doppler of the utero-placental circulation space: A potential screening method for preeclampsia. </em>AJOG. 2010 ;203(3):238.e1-7.</p>
<p style="text-align: left; padding-left: 30px;">27. <strong>Dar P</strong>, Gebb J. <em>Reply: First-trimester 3-dimensional power Doppler for the screening of preeclampsia: the analysis of a greater proportion of the uteroplacental unit might improve the accuracy of the method </em>.AJOG. 2011 Feb;204(2):e5-6.</p>
<p style="text-align: left; padding-left: 30px;">28. Gebb J, Demasio K, <strong>Dar P</strong>. <em>Prenatal sonographic diagnosis of a familial Saethre-Chotzen Syndrome. </em>J Ultrasound Med. 2011;30(3):420-2</p>
<p style="text-align: left; padding-left: 30px;">29. Gebb J, <strong>Dar P</strong>. <em>Color Doppler ultrasound of spiral artery blood flow in the prediction of preeclampsia and intrauterine growth restriction</em>. Best Prac Res Clin Obstet Gynecol. 2011. In press</p>
<p>Pe’er Dar, MD, is Director of Fetal Medicine and OBGYN Ultrasound at Montefiore and Professor of Obstetrics and Gynecology and Women’s Health at our Albert Einstein College of Medicine. Dr. Dar’s clinical focus is on the care of women who carry babies with disorders and medical conditions that may affect their lives and he leads the Fetal Medicine and Surgery Team at Montefiore. He particularly specializes in diagnosis and management of medical and structural abnormalities in the fetus and in complicated twin and triplet pregnancies. His expertise include performing detailed ultrasound examination of the fetus including fetal echocardiography (scanning of the fetal heart) and fetal neurosonography (scanning of the fetal brain) as well as performing in-utero fetal surgeries such as fetoscopic laser surgery for monochorionic twins with twin to twin transfusion syndrome, in-utero blood transfusion for fetuses with anemia and in-utero drainage and shunt procedures. Dr. Dar is also experienced in performing amniocentesis, chorionic villous sampling (CVS) and multifetal selective reduction for multiple pregnancies. </p><p>Dr. Dar completed his Doctor of Medicine from Tel-Aviv University in Tel-Aviv, Israel in 1986. He started his postgraduate education at Assaf Harofe Medical Center, Tel-Aviv University, with a residency in obstetrics and gynecology and a specialty in high-risk pregnancies from 1992 through 1998. He then came to Montefiore-Einstein, completing a two-year fellowship in medical and reproductive genetics. After spending two years as an attending-specialist in the field of prenatal diagnosis he completed in 2005 three-year residency in obstetrics and gynecology at Montefiore-Einstein. In 2007, he completed additional training in fetal surgery in world-known fetal surgery centers in France and Belgium. </p><p>Dr. Dar is very active in research and he is currently the principal investigator in many studies including international multicenter studies. His research focus is in fetal medicine and surgery, non-invasive prenatal screening and placenta accreta spectrum. He has shared his work in many peer-reviewed journals, textbook chapters, abstracts and invited presentations. He is also a reviewer for national and international journals including the <em>American Journal of Obstetrics and Gynecology, Plos one and Prenatal Diagnosis. </em></p><p>Dr. Dar is board certified in both Obstetrics and Gynecology and Clinical Genetics and is a member of several professional societies including the Society of Maternal and Fetal Medicine, International Fetal Medicine and Surgery Society and the International Society of Ultrasound in Obstetrics and Gynecology. He has been regularly listed among Castle Connolly Top Doctors for obstetrics and gynecology in the New York Metro area.</p>